- Home
- / Atossa Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Atossa Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$1.4
2024-10-29
Market Capitalization
$182.3 M
2024-10-29
Revenue
$1.8 K
FY, 2015
CreditSafe Score
?
Score changed on Jun 04, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 481.8K | 632.6K | 526.0K | 1.8K | ||||||||||
| Cost of goods sold | 35.7K | 345.5K | 340.7K | 132.4K | ||||||||||
| Gross profit | 446.1K | 287.0K | 185.3K | (130.7K) | ||||||||||
| Gross profit margin, % | 92.6% | 45.4% | 35.2% | -7431.9% | ||||||||||
| General and administrative expense | 5.0M | 8.6M | 8.6M | 8.8M | 6.5M | 4.9M | 7.2M | 10.6M | 8.0M | 11.3M | 12.6M | 14.0M | 13.5M | 16.0M |
| Operating expense total | 5.5M | 10.9M | 14.8M | 12.6M | 7.2M | 7.2M | 11.4M | 17.3M | 14.6M | 27.7M | 27.6M | 37.1M | ||
| Depreciation and amortization | 16.0K | |||||||||||||
| EBIT | (5.1M) | (10.8M) | (14.6M) | (12.8M) | (8.0M) | (7.6M) | (11.4M) | (17.3M) | (14.6M) | (20.5M) | (27.7M) | (31.4M) | (27.6M) | (37.1M) |
| EBIT margin, % | -1052.0% | -1704.9% | -2784.0% | -725746.2% | ||||||||||
| Interest income | 1.2K | 295.0 | 260.0 | 877.0K | 4.3M | 4.1M | 2.4M | |||||||
| Interest expense | 12.0K | 360.0 | 431.0 | 1.6M | 154.0 | |||||||||
| Pre tax profit | (5.1M) | (10.8M) | (14.7M) | (12.8M) | (6.4M) | (8.1M) | (11.4M) | (17.2M) | (17.8M) | (20.6M) | (27.0M) | (30.1M) | (25.5M) | (34.8M) |
| Net Income | (5.1M) | (10.8M) | (14.7M) | (15.8M) | (6.4M) | (8.1M) | (11.4M) | (17.2M) | (17.8M) | (20.6M) | (27.0M) | (30.1M) | (25.5M) | (34.8M) |
| EPS | (0.2) | (4.0) |